Insulin gene therapy for type 1 diabetes mellitus

Experimental and Clinical Transplantation

Volumn 13, Issue , 2015, Pages 37-45

  Handorf, Andrew M ^a   Sollinger, Hans W ^a   Alam, Tausif ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Autoimmunity; Liver; Minicircle; Pancreas transplant; cell

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ARTICLE; AUTOIMMUNITY; CELL DESTRUCTION; CLINICAL EFFECTIVENESS; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LENTIVIRINAE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PHENOTYPE; SAFETY; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; DIABETES MELLITUS, TYPE 1; GENETICS; LIVER CELL; METABOLISM; PANCREAS TRANSPLANTATION; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENETIC THERAPY; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; PANCREAS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84939795198     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.mesot2014.L67     Document Type: Article

References (48)

1. DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003;289(17):2254- 2264.
2. Kalergis M, Pacaud D, Strychar I, Meltzer S, Jones PJ, Yale JF. Optimizing insulin delivery: assessment of three strategies in intensive diabetes management. Diabetes Obes Metab. 2000;2(5): 299-305.
3. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ. 2002;324(7339):705.
4. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 1967;61(6):827-837.
5. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl. 2008:45-56.
6. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes. 2002;51(12): 3428-3434.
7. Lauria MW, Figueiró JM, Machado LJ, et al. Metabolic long-term follow-up of functioning simultaneous pancreas-kidney trans - plantation versus pancreas transplantation alone: insights and limitations. Transplantation. 2010;89(1):83-87.
8. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230-238.
9. Robertson RP. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med. 2004;350(7):694-705.
10. Cameron MJ, Arreaza GA, Waldhauser L, Gauldie J, Delovitch TL. Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer. Gene Ther. 2000;7(21):1840-1846.
11. Allison J, Thomas H, Beck D, et al. Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. Int Immunol. 2000;12(1):9-17.
12. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 1994;331(21):1428-1436.
13. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008;455(7213):627-632.
14. Li W, Nakanishi M, Zumsteg A, et al. In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. Elife. 2014;3:e01846.
15. Mauda-Havakuk M, Litichever N, Chernichovski E, et al. Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate. PloS One. 2011;6(10): e26298.
16. Li H, Li X, Lam KS, Tam S, Xiao W, Xu R. Adeno-associated virusmediated pancreatic and duodenal homeobox gene-1 expression enhanced differentiation of hepatic oval stem cells to insulinproducing cells in diabetic rats. J Biomed Sci. 2008;15(4):487-497.
17. Lin G, Wang G, Liu G, et al. Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells Dev. 2009;18(10):1399-1406.
18. Ferber S, Halkin A, Cohen H, et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med. 2000;6(5):568-572.
19. Ber I, Shternhall K, Perl S, et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem. 2003;278(34): 31950-31957.
20. Shternhall-Ron K, Quintana FJ, Perl S, et al. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. J Autoimmun. 2007; 28(2-3):134-142.
21. Gefen-Halevi S, Rachmut IH, Molakandov K, et al. NKX6.1 promotes PDX-1-induced liver to pancreatic ß-cells reprogramming. Cell Reprogram. 2010;12(6):655-664.
22. Kaneto H, Nakatani Y, Miyatsuka T, et al. PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes. 2005;54(4):1009-1022.
23. Roep BO, Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med. 2012;2(4):a007781.
24. Efrat S, Tal M, Lodish HF. The pancreatic beta-cell glucose sensor. Trends Biochem Sci. 1994;19(12):535-538.
25. Callejas D, Mann CJ, Ayuso E, et al. Treatment of diabetes and longterm survival after insulin and glucokinase gene therapy. Diabetes. 2013;62(5):1718-1729.
26. Hughes SD, Johnson JH, Quaade C, Newgard CB. Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc Natl Acad Sci U S A. 1992;89(2):688-692.
27. Hughes SD, Quaade C, Johnson JH, Ferber S, Newgard CB. Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism. J Biol Chem. 1993;268(20):15205-15212.
28. Tabiin MT, White CP, Morahan G, Tuch BE. Insulin expressing hepatocytes not destroyed in transgenic NOD mice. J Autoimmune Dis. 2004;1(1):3.
29. Newgard CB. Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Diabetes. 1994;43(3):341-350.
30. Irminger JC, Meyer K, Halban P. Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus. Biochem J. 1996;320 (Pt 1):11-15.
31. Rivera VM, Wang X, Wardwell S, et al. Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science. 2000;287(5454):826-830.
32. Auricchio A, Gao GP, Yu QC, et al. Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Ther. 2002;9(14):963-971.
33. Croze F, Prud'homme GJ. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes. J Gene Med. 2003;5(5):425-437.
34. Alam T, Wai P, Held D, Vakili ST, Forsberg E, Sollinger H. Correction of Diabetic Hyperglycemia and Amelioration of Metabolic Anomalies by Minicircle DNA Mediated Glucose-Dependent Hepatic Insulin Production. PloS One. 2013;8(6):e67515.
35. Kon OL, Sivakumar S, Teoh KL, Lok SH, Long YC. Naked plasmidmediated gene transfer to skeletal muscle ameliorates diabetes mellitus. J Gene Med. 1999;1(3):186-194.
36. Olson DE, Paveglio SA, Huey PU, Porter MH, Thulé PM. Glucoseresponsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats. Hum Gene Ther. 2003;14(15):1401-1413.
37. Alam T, Sollinger HW. Glucose-regulated insulin production in hepatocytes. Transplantation. 2002;74(12):1781-1787.
38. Park YM, Woo S, Lee GT, et al. Safety and efficacy of adenoassociated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats. J Gene Med. 2005;7(5):621-629.
39. Hsu PY, Kotin RM, Yang YW. Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes. Pharm Res. 2008;25(6): 1460-1468.
40. Kolodka TM, Finegold M, Moss L, Woo SL. Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc Natl Acad Sci U S A. 1995;92(8):3293-3297.
41. Muzzin P, Eisensmith RC, Copeland KC, Woo SL. Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol Endocrinol. 1997;11(6):833-837.
42. Ren B, O'Brien BA, Byrne MR, et al. Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy. J Gene Med. 2013;15(1):28-41.
43. Ren B, O'Brien BA, Swan MA, et al. Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia. 2007;50(9):1910-1920.
44. Elsner M, Terbish T, Jörns A, et al. Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction. Mol Ther. 2012;20(5):918-926.
45. Simonson GD, Groskreutz DJ, Gorman CM, MacDonald MJ. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum Gene Ther. 1996;7(1):71-78.
46. Thulé PM, Liu J, Phillips LS. Glucose regulated production of human insulin in rat hepatocytes. Gene Ther. 2000;7(3):205-214.
47. Han J, McLane B, Kim EH, Yoon JW, Jun HS. Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucoseresponsive synthetic promoter. Mol Ther. 2011;19(3):470-478.
48. Thulé PM, Liu JM. Regulated hepatic insulin gene therapy of STZdiabetic rats. Gene Ther. 2000;7(20):1744-1752.